BIomatics to support Cell and Gene Therapy Catapult to accelerate programme of Operational Excellence

The Cell and Gene Therapy Catapult helps companies, researchers and innovators accelerate their cell and gene therapies to market through development, manufacturing and clinical adoption. It was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy, with a vision of a thriving industry delivering life-changing advanced therapies to the world.

Biomatics is a business transformation consultancy who deliver people-focused innovative solutions. With decades of combined experience, their specialist team have worked with notable clients across the Life Sciences and Health and Care sectors to deliver effective, sustainable change.

The programme of Operational Excellence will support the Cell and Gene Therapy Catapult to build continuous improvement across their processes and systems, enabling the highest levels of efficiency, productivity, quality and service.

To support the Cell and Gene Therapy Catapult, Biomatics will work alongside the internal team to continue to build a culture of Operational Excellence, deliver various levels of Lean Six Sigma training and develop a communication and engagement strategy to establish and grow awareness of the programme across the Cell and Gene Therapy Catapult’s sites, stakeholders and collaborators.

With these OpEx principles in place, the Cell and Gene Therapy Catapult will continue to lead from the front in supporting its collaborators to bring groundbreaking cell and gene therapies to the market.
Phil Haynes, Head of Business Excellence at Biomatics, said “We’re delighted to begin this important programme of work with the Cell and Gene Therapy Catapult, and use our extensive experience of Operational Excellence to make a real difference at such an inspiring organisation.”

Dr Stephen Ward, Chief Manufacturing Officer at the Cell and Gene Therapy Catapult added, “We’re committed to supporting our collaborators and the outcomes of our Operational Excellence programme will allow us to provide a more efficient service throughout their journey with us. We’re looking forward to working alongside Biomatics to achieve lasting results.”

To find out more about Cell and Gene Therapy Catapult, visit ct.catapult.org.uk/
To find out more about Biomatics, visit Biomatics.co.uk